Recently, we reported that HS1 expression correlated with poor overall survival in patients with ovarian carcinoma [47], and Liao et al. showed that HS1 is a prognostic marker in pancreatic ductal adenocarcinoma patients [48]. This evidence concerns the gene HCLS1 and ovarian carcinoma.